Multifunctional Micelles Dually Responsive to Hypoxia and Singlet Oxygen: Enhanced Photodynamic Therapy via Interactively Triggered Photosensitizer Delivery
Source abstract
Abstract
Nanoparticulate antitumor photodynamic therapy (PDT) has been suffering from the limited dose accumulation in tumor. Herein, we report dually hypoxia- and singlet oxygen-responsive polymeric micelles to efficiently utilize the photosensitizer deposited in the disease site and hence facilely improve PDT's antitumor efficacy. Tailored methoxy poly(ethylene glycol)-azobenzene-poly(aspartic acid) copolymer conjugate with imidazole as the side chains was synthesized. The conjugate micelles (189 ± 19 nm) obtained by self-assembly could efficiently load a model photosensitizer, chlorin e6 (Ce6) with a loading of 4.1 ± 0.5% (w/w). The facilitated cellular uptake of micelles was achieved by the triggered azobenzene collapse that provoked poly(ethylene glycol) shedding; rapid Ce6 release was enabled by imidazole oxidation that induced micelle disassembly. In addition, the singlet oxygen-mediated cargo release not only addressed the limited diffusion range and short half-life of singlet oxygen but also decreased the oxygen level, which could in turn enhance internalization and increase the intracellular Ce6 concentration. The hypoxia-induced dePEGylation and singlet oxygen-triggered Ce6 release was demonstrated both in aqueous buffer and in Lewis lung carcinoma (LLC) cells. The cellular uptake study demonstrated that the dually responsive micelles could deliver significantly more Ce6 to the cells, which resulted in a substantially improved cytotoxicity. This concurred well with the superior in vivo antitumor ability of micelles in a LLC tumor-bearing mouse model. This study presented an intriguing nanoplatform to realize interactively triggered photosensitizer delivery and improved antitumor PDT efficacy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Pharmaceutical Science & Technology, Tianjin Key Laboratory for Modern Drug Delivery & High Efficiency, and Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Tianjin University, Tianjin 300072, China
Funding
Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China · State Key Laboratory of Medicinal Chemical Biology, Nankai University
References (49)
Show source-provided references
1. 10.1093/jnci/90.12.88910.1093/jnci/90.12.889 ↗
2. 10.1038/nrc107110.1038/nrc1071 ↗
3. 10.1021/cr500419810.1021/cr5004198 ↗
4. 10.1002/anie.20160550910.1002/anie.201605509 ↗
5. 10.1016/j.jconrel.2017.05.02510.1016/j.jconrel.2017.05.025 ↗
6. 10.1016/j.jconrel.2011.06.00110.1016/j.jconrel.2011.06.001 ↗
7. 10.1038/natrevmats.2016.1410.1038/natrevmats.2016.14 ↗
8. 10.1016/j.jconrel.2011.09.06310.1016/j.jconrel.2011.09.063 ↗
9. 10.1073/pnas.171339011410.1073/pnas.1713390114 ↗
10. 10.1562/2006-04-14-ir-87410.1562/2006-04-14-ir-874 ↗
11. 10.1073/pnas.061132810410.1073/pnas.0611328104 ↗
12. 10.1016/j.jphotobiol.2009.11.01310.1016/j.jphotobiol.2009.11.013 ↗
13. 10.1016/j.addr.2015.09.01210.1016/j.addr.2015.09.012 ↗
14. 10.1002/anie.20160223310.1002/anie.201602233 ↗
15. 10.1016/j.ijpharm.2011.02.00510.1016/j.ijpharm.2011.02.005 ↗
16. 10.1038/nbt.333010.1038/nbt.3330 ↗
17. 10.1039/c6nr02174c10.1039/c6nr02174c ↗
18. 10.1021/acsami.7b0280810.1021/acsami.7b02808 ↗
19. 10.1021/acs.bioconjchem.7b0033010.1021/acs.bioconjchem.7b00330 ↗
20. 10.1016/j.cell.2011.02.01310.1016/j.cell.2011.02.013 ↗
21. 10.1016/s0168-3659(03)00232-310.1016/s0168-3659(03)00232-3 ↗
22. 10.1021/bc300266y10.1021/bc300266y ↗
23. 10.1021/jacs.5b0960210.1021/jacs.5b09602 ↗
24. 10.1002/anie.20150950710.1002/anie.201509507 ↗
25. 10.1002/anie.20130836810.1002/anie.201308368 ↗
26. 10.1007/978-1-4939-3148-4_1210.1007/978-1-4939-3148-4_12 ↗
27. 10.1021/acs.biomac.6b0035010.1021/acs.biomac.6b00350 ↗
28. 10.1021/bm400358z10.1021/bm400358z ↗
29. 10.1021/am505951910.1021/am5059519 ↗
30. 10.1021/bm500711c10.1021/bm500711c ↗
31. 10.1038/nmat377610.1038/nmat3776 ↗
32. 10.1016/j.addr.2012.01.02010.1016/j.addr.2012.01.020 ↗
33. 10.1002/advs.20160012410.1002/advs.201600124 ↗
34. 10.1016/j.biomaterials.2017.09.00710.1016/j.biomaterials.2017.09.007 ↗
35. 10.1016/j.jconrel.2017.04.00210.1016/j.jconrel.2017.04.002 ↗
36. 10.1016/j.biomaterials.2017.03.01010.1016/j.biomaterials.2017.03.010 ↗
37. 10.1021/ja00967a02910.1021/ja00967a029 ↗
38. 10.1002/anie.20150047810.1002/anie.201500478 ↗
39. 10.1002/adfm.20170408910.1002/adfm.201704089 ↗
40. 10.1021/acs.chemrev.5b0029210.1021/acs.chemrev.5b00292 ↗
41. 10.1016/j.jconrel.2011.12.02110.1016/j.jconrel.2011.12.021 ↗
42. 10.1007/s11095-012-0848-810.1007/s11095-012-0848-8 ↗
43. 10.1007/s11095-007-9463-510.1007/s11095-007-9463-5 ↗
44. 10.1039/c7nr00808b10.1039/c7nr00808b ↗
45. 10.1021/ja407514z10.1021/ja407514z ↗
46. 10.1016/s0168-3659(99)00248-510.1016/s0168-3659(99)00248-5 ↗
47. 10.1016/j.tibtech.2008.07.00710.1016/j.tibtech.2008.07.007 ↗
48. 10.1021/acsami.6b0942510.1021/acsami.6b09425 ↗
49. 10.1155/2014/51651810.1155/2014/516518 ↗